Loading clinical trials...
Loading clinical trials...
Ropinirole has shown to improve mood in depressed patients as well as to improve the symptoms of Restless Legs Syndrome. Up to 40% of RLS patients suffer from mild depression, therefore it would be im...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
GlaxoSmithKline
NCT07001891 · Restless Legs Syndrome
NCT06684782 · Restless Legs Syndrome
NCT05908214 · Stroke, Cramp, and more
NCT05321355 · Sleep Disorder, Sleep Disorder Parasomnia, and more
NCT02670161 · Brain Tumors, Epilepsy, and more
GSK Investigational Site
Ellwangen, Baden-Wurttemberg
GSK Investigational Site
Freiburg im Breisgau, Baden-Wurttemberg
GSK Investigational Site
Ostfildern, Baden-Wurttemberg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions